Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | completed | Phase 2 / Phase 3 | 426 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00478634 | A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 19 | Novartis PharmaceuticalsINDUSTRY | 1 |
| Nov 2, 2012 |
| clinicaltrials |
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 52 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569790 | Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 53 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 107 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00849394 | Evaluation of Protein in the Urine in Patients Receiving Bevacizumab | completed | — | 106 | North Texas Veterans Healthcare SystemFED | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00030524 | ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT01346917 | Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery | completed | N/A | 77 | Kangbuk Samsung HospitalOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01189877 | Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins | completed | N/A | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00436072 | ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00597610 | Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound | completed | N/A | 84 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00005640 | Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | completed | N/A | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 430 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 86 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 64 | Hoffmann-La RocheINDUSTRY | 3 | Sep 18, 2012 | clinicaltrials |
| NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | completed | Phase 1 | 119 | AmgenINDUSTRY | 0 | Sep 17, 2012 | clinicaltrials |
| NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00981110 | Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer Surgery(AM) | completed | Phase 3 | 120 | European Institute of OncologyOTHER | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00136227 | Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women | completed | N/A | 521 | Centers for Disease Control and PreventionFED | 1 | Sep 7, 2012 | clinicaltrials |
| NCT00137592 | Promoting Colorectal Cancer Screening in Rural Colorado | completed | N/A | 480 | Centers for Disease Control and PreventionFED | 1 | Sep 7, 2012 | clinicaltrials |
| NCT01072851 | Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print | completed | Phase 3 | 920 | Trinity Health Of New EnglandOTHER | 1 | Sep 7, 2012 | clinicaltrials |
| NCT01575340 | Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer | completed | N/A | 11 | Universidade Federal de Santa CatarinaOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00607282 | Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer | completed | Phase 2 | 46 | Seoul National University HospitalOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | completed | Phase 1 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01251666 | Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening(HeMO) | completed | Phase 3 | 19,797 | University Hospital, CaenOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00660153 | Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers | completed | Phase 1 | 30 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 28, 2012 | clinicaltrials |
| NCT01671683 | Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer | completed | — | 44 | Chungnam National UniversityOTHER | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00661154 | Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project | completed | — | 7 | Stanford UniversityOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 10 | Aug 7, 2012 | clinicaltrials |
| NCT00113230 | Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer | completed | Phase 2 | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01269060 | Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery | completed | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 6, 2012 | clinicaltrials |
| NCT00507351 | Ambulatory Cancer Pain Management: A Feasibility Study | completed | — | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00003046 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | completed | Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00838318 | Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients | completed | — | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01053104 | Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring(DATACAP) | completed | — | 26 | University of OxfordOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00502502 | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | completed | — | 205 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00862342 | Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)(SAFE) | completed | Phase 2 | 78 | Asan Medical CenterOTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT01637194 | Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer | completed | Phase 1 | 12 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 16 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 4, 2012 | clinicaltrials |
| NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 3 | 554 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 2, 2012 | clinicaltrials |
| NCT01628328 | Colonic Stent and Tumor Cell Dissemination | completed | — | 40 | The University of Hong KongOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT00594113 | "Touch 2 Screen" Multi-media Colorectal Cancer Screening Intervention | completed | N/A | 470 | Allen A. Greiner, MD, MPHOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01623258 | A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma | completed | — | 34 | Walter Reed Army Medical CenterFED | 1 | Jun 19, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Nov 2, 2012source: clinicaltrials